Clinical Trial Update: A Safety Study of Dapivirine Vaginal Ring in Africa [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 safety trial evaluating the dapivirine vaginal ring for HIV prevention in Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED